Overexpression of forkhead box J2 can decrease the migration of breast cancer cells

Journal of Cellular Biochemistry

Volumn 113, Issue 8, 2012, Pages 2729-2737

  Wang, Yingying ^a,b   Yang, Shuyun ^b   Ni, Qichao ^b   He, Song ^b   Zhao, Yunhong ^a   Yuan, Qin ^a   Li, Chunmiao ^a   Chen, Hongwei ^a   Zhang, Li ^b   Zou, Lin ^c   Shen, Aiguo ^b   Cheng, Chun ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

^c Yancheng First People's Hospital   (China)

Author keywords

Breast cancer cells; E cadherin; Forkhead box J2 (FoxJ2); Metastases

Indexed keywords

FORKHEAD BOX J2; FORKHEAD TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862580650     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24146     Document Type: Article

References (49)

1. Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. 2010. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 122:337-346.
2. Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. 2011. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 112:2296-2306.
3. Birkenkamp KU, Coffer PJ. 2003. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 31:292-297. (Pubitemid 36241447)
4. Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, Cheung AN, Ngan HY. 2008a Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 215:245-252. (Pubitemid 351956705)
5. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, Hong W. 2008b A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68:2592-2598. (Pubitemid 351556257)
6. Coffer PJ, Burgering BM. 2004. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4:889-899. (Pubitemid 39490764)
7. Coleman KA, Greenberg RA. 2011. The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J Biol Chem 286:13669-13680.
8. Di Pietro N, Panel V, Hayes S, Bagattin A, Meruvu S, Pandolfi A, Hugendubler L, Fejes-Toth G, Naray-Fejes-Toth A, Mueller E. 2010. Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1. Mol Endocrinol 24:370-380.
9. Du J, Li L, Ou Z, Kong C, Zhang Y, Dong Z, Zhu S, Jiang H, Shao Z, Huang B, Lu J. 2011. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Breast Cancer Res Treat 131:65-73.
10. Eccles SA, Welch DR. 2007. Metastasis: Recent discoveries and novel treatment strategies. Lancet 369:1742-1757. (Pubitemid 46755391)
11. Erickson MG, Moon DL, Yue DT. 2003. DsRed as a potential FRET partner with CFP and GFP. Biophys J 85:599-611. (Pubitemid 36753662)
12. Granadino B, Arias-de-la-Fuente C, Perez-Sanchez C, Parraga M, Lopez-Fernandez LA, del Mazo J, Rey-Campos J. 2000. Fhx (Foxj2) expression is activated during spermatogenesis and very early in embryonic development. Mech Dev 97:157-160.
13. Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS. 2011. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 10:10.
14. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70. (Pubitemid 30046295)
15. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-674.
16. Hartmann W, Sobin L, Stalsberg H. 1981. Histological typing of breast tumours. In Organization WH, editor. Geneva: International Classification of Tumours. pp 15-25.
17. Hinestrosa MC, Dickersin K, Klein P, Mayer M, Noss K, Slamon D, Sledge G, Visco FM. 2007. Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Nat Rev Cancer 7:309-315. (Pubitemid 46480973)
18. Kalinichenko VV, Gusarova GA, Shin B, Costa RH. 2003. The forkhead box F1 transcription factor is expressed in brain and head mesenchyme during mouse embryonic development. Gene Expr Patterns 3:153-158. (Pubitemid 36503664)
19. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428.
20. Kaneda H, Arao T, Tanaka K, Tamura D, Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y, Yamada Y, Tsurutani J, Okamoto I, Nakagawa K, Nishio K. 2010. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res 70:2053-2063.
21. Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K, Momoi M, Miura Y, Ozawa K, Komatsu N. 2000. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96:941-949. (Pubitemid 30616858)
22. Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, Ishikawa T, Wakasa K, Hirakawa K. 2010. Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 103:249-255.
23. Katoh M. 2004. Human FOX gene family (Review). Int J Oncol 25:1495-1500.
24. Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, Harrison DJ. 2011. An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. PLoS ONE 6:e17083.
25. Kehn K, Berro R, Alhaj A, Bottazzi ME, Yeh WI, Klase Z, Van Duyne R, Fu S, Kashanchi F. 2007. Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells. Oncogene 26:5060-5069. (Pubitemid 47206950)
26. Lo PK, Lee JS, Liang X, Han L, Mori T, Fackler MJ, Sadik H, Argani P, Pandita TK, Sukumar S. 2010. Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res 70:6047-6058.
27. Lok GT, Chan DW, Liu VW, Hui WW, Leung TH, Yao KM, Ngan HY. 2011. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS ONE 6:e23790.
28. Malin D, Kim IM, Boetticher E, Kalin TV, Ramakrishna S, Meliton L, Ustiyan V, Zhu X, Kalinichenko VV. 2007. Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. Mol Cell Biol 27:2486-2498. (Pubitemid 46581341)
29. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA. 2007. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 104:10069-10074. (Pubitemid 47175264)
30. Martin-de-Lara F, Sanchez-Aparicio P, Arias de la Fuente C, Rey-Campos J. 2008. Biological effects of FoxJ2 over-expression. Transgenic Res 17:1131-1141.
31. Mehta RJ, Jain RK, Leung S, Choo J, Nielsen T, Huntsman D, Nakshatri H, Badve S. 2011. FOXA1 is an independent prognostic marker for ER-positive breast cancer. Breast Cancer Res Treat 131:881-890.
32. Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, Conte M, Fini M, Giavaresi G, Berti P, Miccoli P. 2006. Metastatic breast cancer: An updating. Biomed Pharmacother 60:548-556.
33. Nilsson J, Helou K, Kovacs A, Bendahl PO, Bjursell G, Ferno M, Carlsson P, Kannius-Janson M. 2010. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res 70:2020-2029.
34. Perez-Sanchez C, Gomez-Ferreria MA, de La Fuente CA, Granadino B, Velasco G, Esteban-Gamboa A, Rey-Campos J. 2000. FHX, a novel fork head factor with a dual DNA binding specificity. J Biol Chem 275:12909-12916. (Pubitemid 30241447)
35. Rosen EM, Fan S, Ma Y. 2006. BRCA1 regulation of transcription. Cancer Lett 236:175-185.
36. Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J, Vesterinen T, Nordling S, Kallioniemi O, Hautaniemi S, Janne OA. 2011. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J 30:3962-3976.
37. Shi H, Gu Y, Yang J, Xu L, Mi W, Yu W. 2008. Lipocalin 2 promotes lung metastasis of murine breast cancer cells. J Exp Clin Cancer Res 27:83.
38. Shiota M, Song Y, Yokomizo A, Kiyoshima K, Tada Y, Uchino H, Uchiumi T, Inokuchi J, Oda Y, Kuroiwa K, Tatsugami K, Naito S. 2010. Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation. Clin Cancer Res 16:5654-5663.
39. Song Y, Washington MK, Crawford HC. 2010. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res 70:2115-2125.
40. Storz P, Doppler H, Copland JA, Simpson KJ, Toker A. 2009. FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. Mol Cell Biol 29:4906-4917.
41. Tallon B, Bhawan J. 2010. FoxP3 expression is increased in cutaneous squamous cell carcinoma with perineural invasion. J Cutan Pathol 37:1184-1185.
42. Tang Y, Shu G, Yuan X, Jing N, Song J. 2011. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. Cell Res 21:316-326.
43. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142. (Pubitemid 43278296)
44. Ustiyan V, Wang IC, Ren X, Zhang Y, Snyder J, Xu Y, Wert SE, Lessard JL, Kalin TV, Kalinichenko VV. 2009. Forkhead box M1 transcriptional factor is required for smooth muscle cells during embryonic development of blood vessels and esophagus. Dev Biol 336:266-279.
45. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF. 2008. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 283:20770-20778.
46. Weigel D, Jurgens G, Kuttner F, Seifert E, Jackle H. 1989. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57:645-658.
47. Xie Y, Wolff DW, Wei T, Wang B, Deng C, Kirui JK, Jiang H, Qin J, Abel PW, Tu Y. 2009. Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res 69:5743-5751.
48. Zeng J, Wang L, Li Q, Li W, Bjorkholm M, Jia J, Xu D. 2009. FoxM1 is upregulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol 218:419-427.
49. Zhang HY, Sun H. 2010. Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett 287:91-97.